A patient with type 2 diabetes has eGFR 43 mL/min/1.73 m² and ACR 74 mg/mmol despite maximally tolerated losartan and an SGLT2 inhibitor. Potassium

Question

A patient with type 2 diabetes has eGFR 43 mL/min/1.73 m² and ACR 74 mg/mmol despite maximally tolerated losartan and an SGLT2 inhibitor. Potassium is 4.5 mmol/L. Which further cardiorenal option should be assessed with potassium monitoring?

Accepted Answer

Add finerenone with planned potassium and eGFR review

Answer

Add a DPP-4 inhibitor with A1c and weight review

Answer

Add a sulfonylurea with structured hypoglycemia review

Answer

Add pioglitazone with edema and weight review

Answer

Stop losartan before adding basal insulin for glycaemia

Asymptomatic bacteriuria — RCPSC IM MCQ

A patient with type 2 diabetes has eGFR 43 mL/min/1.73 m² and ACR 74 mg/mmol despite maximally tolerated losartan and an SGLT2 inhibitor. Potassium is 4.5 mmol/L. Which further cardiorenal option should be assessed with potassium monitoring?